As if Cleveland needed any more trouble, the two leading banks in the city are rumored to be considering a merger or even an outright sale. According to The Wall Street Journal, KeyCorp. (NYSE: KEY) may acquire National City Corp. (NYSE: NCC). Buyout firm Kohlberg Kravis Roberts & Co. could provide the capital for the buyout.
National City has had a difficult few months. The bank has a lot of exposure to the subprime mortgage market, and the company's stock has dropped from the mid $30s to about $10 in the last year. Although National City has a $1 billion stake in Visa (NYSE: V), it has laid off over 3,000 workers recently, and is likely to reduce staff even further. An acquisition by neighbor KeyCorp. would no doubt guarantee many more firings -- or "redundancies," as they say in Britain.
So far, these rumors are good news for KeyCorp, which is up nearly 5% to $24.66. For National City, it's a different story, with the stock down nearly 2% to $9.78. I guess the market thinks KeyCorp. will pick up some decent assets at fire sale prices. Let's hope that this isn't another mistake by the lake.
Last updated: February 09, 2012: 11:05 AM
Hot Stocks
DailyFinance Headlines
- BlackBerry Loses to Apple Again
- DVDs Are Dying, and There's Worse News Ahead for Hollywood
- The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
- Twice the Heart, Half the Cost: Our Readers' Budget Valentine's Day Suggestions
- Is an Amazon Store in the Real World a Good Idea?
Benzinga Headlines
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
- CVS Profit Up as Walgreen's Customers Defect
TheFlyOnTheWall.com Headlines
- DOJ announces $25B settlement with five largest mortgage servicers
- Apple to unveil iPad 3 in first week of March, All Things D says
- On The Fly: Analyst Initiation Summary
- On The Fly: Analyst Downgrade Summary
- On The Fly: Analyst Upgrade Summary
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- BlackBerry Loses to Apple Again
- DVDs Are Dying, and There's Worse News Ahead for Hollywood
- The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
- Twice the Heart, Half the Cost: Our Readers' Budget Valentine's Day Suggestions
- Is an Amazon Store in the Real World a Good Idea?
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

